LXN and lymphoma: To test the hypothesis that Lxn promoter hypermethylation might be involved in the loss of expression in leukemia and lymphoma cell lines, we studied the effect of 5-aza-2′-deoxycytidine, a DNA demethylating reagent, on Lxn expression (Fig. 2C).